Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives. 2006

Yun-Fei Li, and Gui-Feng Wang, and Pei-Lan He, and Wei-Gang Huang, and Feng-Hua Zhu, and He-Yong Gao, and Wei Tang, and Yu Luo, and Chun-Lan Feng, and Li-Ping Shi, and Yu-Dan Ren, and Wei Lu, and Jian-Ping Zuo
State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, SIBS, Chinese Academy of Sciences, 555 Zuchongzhi Road, Zhangjiang Hi-Tech Park, Shanghai 201203, China.

A series of novel benzimidazole derivatives was synthesized and evaluated for their anti-hepatitis B virus (HBV) activity and cytotoxicity in vitro. Strong activity against HBV replication and low cytotoxicity were generally observed in these benzimidazoles. The most promising compounds were 12a and 12b, with similar high antiviral potency (IC50 = 0.9 and 0.7 microM, respectively) and remarkable selectivity indices (>1111 and 714, respectively). They were selected for further evaluation as novel HBV inhibitors.

UI MeSH Term Description Entries
D004279 DNA, Viral Deoxyribonucleic acid that makes up the genetic material of viruses. Viral DNA
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Yun-Fei Li, and Gui-Feng Wang, and Pei-Lan He, and Wei-Gang Huang, and Feng-Hua Zhu, and He-Yong Gao, and Wei Tang, and Yu Luo, and Chun-Lan Feng, and Li-Ping Shi, and Yu-Dan Ren, and Wei Lu, and Jian-Ping Zuo
July 2010, Bioorganic & medicinal chemistry,
Yun-Fei Li, and Gui-Feng Wang, and Pei-Lan He, and Wei-Gang Huang, and Feng-Hua Zhu, and He-Yong Gao, and Wei Tang, and Yu Luo, and Chun-Lan Feng, and Li-Ping Shi, and Yu-Dan Ren, and Wei Lu, and Jian-Ping Zuo
February 2011, Archiv der Pharmazie,
Yun-Fei Li, and Gui-Feng Wang, and Pei-Lan He, and Wei-Gang Huang, and Feng-Hua Zhu, and He-Yong Gao, and Wei Tang, and Yu Luo, and Chun-Lan Feng, and Li-Ping Shi, and Yu-Dan Ren, and Wei Lu, and Jian-Ping Zuo
February 2015, Bioorganic & medicinal chemistry,
Yun-Fei Li, and Gui-Feng Wang, and Pei-Lan He, and Wei-Gang Huang, and Feng-Hua Zhu, and He-Yong Gao, and Wei Tang, and Yu Luo, and Chun-Lan Feng, and Li-Ping Shi, and Yu-Dan Ren, and Wei Lu, and Jian-Ping Zuo
May 2012, Bioorganic & medicinal chemistry,
Yun-Fei Li, and Gui-Feng Wang, and Pei-Lan He, and Wei-Gang Huang, and Feng-Hua Zhu, and He-Yong Gao, and Wei Tang, and Yu Luo, and Chun-Lan Feng, and Li-Ping Shi, and Yu-Dan Ren, and Wei Lu, and Jian-Ping Zuo
January 2017, MedChemComm,
Yun-Fei Li, and Gui-Feng Wang, and Pei-Lan He, and Wei-Gang Huang, and Feng-Hua Zhu, and He-Yong Gao, and Wei Tang, and Yu Luo, and Chun-Lan Feng, and Li-Ping Shi, and Yu-Dan Ren, and Wei Lu, and Jian-Ping Zuo
September 2016, Bioorganic & medicinal chemistry letters,
Yun-Fei Li, and Gui-Feng Wang, and Pei-Lan He, and Wei-Gang Huang, and Feng-Hua Zhu, and He-Yong Gao, and Wei Tang, and Yu Luo, and Chun-Lan Feng, and Li-Ping Shi, and Yu-Dan Ren, and Wei Lu, and Jian-Ping Zuo
January 2016, Acta poloniae pharmaceutica,
Yun-Fei Li, and Gui-Feng Wang, and Pei-Lan He, and Wei-Gang Huang, and Feng-Hua Zhu, and He-Yong Gao, and Wei Tang, and Yu Luo, and Chun-Lan Feng, and Li-Ping Shi, and Yu-Dan Ren, and Wei Lu, and Jian-Ping Zuo
May 2012, Bioorganic & medicinal chemistry letters,
Yun-Fei Li, and Gui-Feng Wang, and Pei-Lan He, and Wei-Gang Huang, and Feng-Hua Zhu, and He-Yong Gao, and Wei Tang, and Yu Luo, and Chun-Lan Feng, and Li-Ping Shi, and Yu-Dan Ren, and Wei Lu, and Jian-Ping Zuo
January 2005, Bioorganic & medicinal chemistry letters,
Yun-Fei Li, and Gui-Feng Wang, and Pei-Lan He, and Wei-Gang Huang, and Feng-Hua Zhu, and He-Yong Gao, and Wei Tang, and Yu Luo, and Chun-Lan Feng, and Li-Ping Shi, and Yu-Dan Ren, and Wei Lu, and Jian-Ping Zuo
May 2014, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!